XML 47 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statement Of Changes In Redeemable Convertible Preferred Stock And Stockholders' (Deficit) Equity (USD $)
In Thousands, except Share data
Total
USD ($)
Series A 12% convertible preferred stock
USD ($)
Series C super dividend convertible preferred stock
USD ($)
Series B-1 12% redeemable convertible preferred stock
USD ($)
Series B-2 12% redeemable convertible preferred stock
USD ($)
Series C super dividend convertible preferred stock
USD ($)
Series A 12% convertible preferred stock
USD ($)
Common Stock
USD ($)
Common Stock
Series A 12% convertible preferred stock
Common Stock
Series B-1 12% redeemable convertible preferred stock
Common Stock
Series B-2 12% redeemable convertible preferred stock
Common Stock
Series C super dividend convertible preferred stock
Additional Paid-In Capital
USD ($)
Additional Paid-In Capital
Series A 12% convertible preferred stock
USD ($)
Additional Paid-In Capital
Series B-1 12% redeemable convertible preferred stock
USD ($)
Additional Paid-In Capital
Series B-2 12% redeemable convertible preferred stock
USD ($)
Additional Paid-In Capital
Series C super dividend convertible preferred stock
USD ($)
Deficit Accumulated During the Development Stage
USD ($)
Deficit Accumulated During the Development Stage
Series A 12% convertible preferred stock
USD ($)
Deficit Accumulated During the Development Stage
Series B-1 12% redeemable convertible preferred stock
USD ($)
Deficit Accumulated During the Development Stage
Series B-2 12% redeemable convertible preferred stock
USD ($)
Deficit Accumulated During the Development Stage
Series C super dividend convertible preferred stock
USD ($)
Beginning Balance at Dec. 31, 2012 $ 1,165     $ 1,698 $ 2,900 $ 2,154 $ 632 $ 16         $ 80,535         $ (80,018)        
Beginning Balance (in shares) at Dec. 31, 2012       900,000 2,100,000 220 1,562,500 16,060,853                            
Accretion of Series B redeemable convertible preferred stock (43)     4 39                         (43)        
Accretion of beneficial conversion feature for Series B-2 (13)       13                         (13)        
Convertible preferred stock dividend (in shares)                 15,625 14,580 34,020 17,114                    
Convertible preferred stock dividend   47 33                     57 52 122 62   (10) (52) (122) (29)
Conversion of Series C to common stock (in shares)           (5)   8,475                            
Conversion of Series C to common stock 49         (49)             49                  
Issuance of common stock upon exercise of options (in shares) 39,762             39,762                            
Issuance of common stock upon exercise of options 77                       77                  
Stock-based compensation expense 852                       852                  
Net loss (3,203)                                 (3,203)        
Ending Balance at Mar. 31, 2013 $ (1,036)     $ 1,702 $ 2,952 $ 2,105 $ 632 $ 16         $ 81,806         $ (83,490)        
Ending Balance (in shares) at Mar. 31, 2013       900,000 2,100,000 215 1,562,500 16,190,429